乳腺癌骨转移相关生物标志物研究进展
Research Progress of Biomarkers Related to Bone Metastasis of Breast Cancer
摘要: 全球范围内，乳腺癌是发病率最高的女性恶性肿瘤。骨转移是乳腺癌患者最常见的并发症之一，约占所有转移性乳腺癌患者的65%至75%，而且出现骨转移会极大地影响乳腺癌患者生存质量及预后。所以寻找有效的方法诊断乳腺癌的骨转移，做到尽早干预、治疗，对于提高患者生存质量意义非凡。肿瘤标志物已成为乳腺癌治疗和监测的重要手段，但目前尚缺乏特异性标志物用于乳腺癌骨转移的早期诊断、疗效评估和预后判断等。本文主要从几项与乳腺癌骨转移诊断相关的生物标志物的最新研究进展进行阐述，以期为临床诊治提供参考。
Abstract: Breast cancer is the most common malignant tumor in women worldwide. Bone metastasis is one of the most common complications in breast cancer patients, accounting for about 65% to 75% of all metastatic breast cancer patients, and the occurrence of bone metastasis will greatly affect the quality of life and prognosis of breast cancer patients. Therefore, it is of great significance to find an effective method to diagnose bone metastasis of breast cancer and to intervene and treat it as soon as possible to improve the quality of life of patients. Tumor markers have become an important means of treatment and monitoring of breast cancer, but there is still a lack of specific markers for early diagnosis, efficacy evaluation and prognosis of bone metastasis of breast cancer. This article mainly reviews the latest research progress of several biomarkers related to the diagnosis of bone metastasis of breast cancer, in order to provide reference for clinical diagnosis and treatment.
文章引用：黄子静, 马雨琪, 李雨婷, 刘定定, 杨卫卫. 乳腺癌骨转移相关生物标志物研究进展[J]. 临床医学进展, 2024, 14(4): 2905-2913. https://doi.org/10.12677/acm.2024.1441371

参考文献

[1] Tao, X., Li, T., Gandomkar, Z., et al. (2023) Incidence, Mortality, Survival, and Disease Burden of Breast Cancer in China Compared to Other Developed Countries. Asia-Pacific Journal of Clinical Oncology, 19, 645-654. [Google Scholar] [CrossRef] [PubMed]
[2] Scimeca, M., Trivigno, D., Bonfiglio, R., et al. (2021) Breast Cancer Metastasis to Bone: From Epithelial to Mesenchymal Transition to Breast Osteoblast-Like Cells. Seminars in Cancer Biology, 72, 155-164. [Google Scholar] [CrossRef] [PubMed]
[3] Sakata, T., Maeda, H., Yamasaki, K., et al. (1982) [Evaluation of CT and Demonstration of ECT Images on Skeletal Lesion in Cases of Post-Operative Breast Cancer]. Nihon Igaku Hoshasen Gakkai Zasshi, 42, 370-379.
[4] Pan, Y., Lin, Y. and Mi, C. (2021) Clinicopathological Characteristics and Prognostic Risk Factors of Breast Cancer Patients with Bone Metastasis. Annals of Translational Medicine, 9, Article 1340. [Google Scholar] [CrossRef] [PubMed]
[5] Zhang, J., Wei, Q., Dong, D., et al. (2021) The Role of TPS, CA125, CA15-3 and CEA in Prediction of Distant Metastasis of Breast Cancer. Clinica Chimica Acta, 523, 19-25. [Google Scholar] [CrossRef] [PubMed]
[6] Feng, C., Zhan, Y., Shao, H., et al. (2020) Postoperative Expressions of TRACP5b and CA125 in Patients with Breast Cancer and Their Values for Monitoring Bone Metastasis. Journal of BUON, 25, 688-695.
[7] 赵庆杰, 尤军. 放射性核素骨显像联合血清CA125、CA15-3、CEA水平检测在乳腺癌骨转移诊断中的应用价值[J]. 河南医学研究, 2017, 26(21): 3871-3873.
[8] Jiang, C., Hu, F., Xia, X., et al. (2023) Prognostic Value of Alkaline Phosphatase and Bone-Specific Alkaline Phosphatase in Breast Cancer: A Systematic Review and Meta-Analysis. The International Journal of Biological Markers, 38, 25-36. [Google Scholar] [CrossRef] [PubMed]
[9] Tayubi, I.A. and Madar, I.H. (2022) Biomineralization Associated Alkaline Phosphatase as a Potential Marker of Bone Metastasis in the Patients with Invasive Breast Cancer. Saudi Journal of Biological Science, 29, Article ID: 103340. [Google Scholar] [CrossRef] [PubMed]
[10] Wu, Q., Tian, P., He, D., et al. (2023) SCUBE2 Mediates Bone Metastasis of Luminal Breast Cancer by Modulating Immune-Suppressive Osteoblastic Niches. Cell Research, 33, 464-478. [Google Scholar] [CrossRef] [PubMed]
[11] Liu, M., Sui, L., Fang, Z., et al. (2023) Aberrant Expression of Bone Morphogenetic Proteins in the Disease Progression and Metastasis of Breast Cancer. Frontiers in Oncology, 13, Article 1166955. [Google Scholar] [CrossRef] [PubMed]
[12] Puppo, M., Valluru, M.K., Croset, M., et al. (2023) MiR-662 Is Associated with Metastatic Relapse in Early-Stage Breast Cancer and Promotes Metastasis by Stimulating Cancer Cell Stemness. British Journal of Cancer, 129, 754-771. [Google Scholar] [CrossRef] [PubMed]
[13] Chen, B., Dai, D., Tang, H., et al. (2016) Pre-Treatment Serum Alkaline Phosphatase and Lactate Dehydrogenase as Prognostic Factors in Triple Negative Breast Cancer. Journal of Cancer, 7, 2309-2316. [Google Scholar] [CrossRef] [PubMed]
[14] Yoo, T.K., Chae, B.J., Kim, S.J., et al. (2017) Identifying Long-Term Survivors among Metastatic Breast Cancer Patients Undergoing Primary Tumor Surgery. Breast Cancer Research and Treatment, 165, 109-118. [Google Scholar] [CrossRef] [PubMed]
[15] Rao, H., Wu, H., Huang, Q., et al. (2021) Clinical Value of Serum CEA, CA24-2 and CA19-9 in Patients with Colorectal Cancer. Clinical Laboratory, 67. [Google Scholar] [CrossRef] 
[16] Corso, G., Gilardi, L., Girardi, A., et al. (2020) How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance? Oncology, 98, 714-718. [Google Scholar] [CrossRef] [PubMed]
[17] Chen, W.Z., Shen, J.F., Zhou, Y., et al. (2017) Clinical Characteristics and Risk Factors for Developing Bone Metastases in Patients with Breast Cancer. Scientific Reports, 7, Article No. 11325. [Google Scholar] [CrossRef] [PubMed]
[18] Araz, M., Beypinar, I., Kazan, S., et al. (2019) Are Preoperative Serum CA15-3 Levels Different in Breast Cancer Subgroups? Current Problems in Cancer, 43, 115-122. [Google Scholar] [CrossRef] [PubMed]
[19] 熊炳钧, 黄静, 袁可玉, 等. 骨转换标志物与肿瘤标志物在骨转移诊断中的价值[J]. 肿瘤代谢与营养电子杂志, 2023, 10(5): 633-638.
[20] Wang, X., Li, Y., Tong, J., et al. (2019) Endometriosis Presenting with Recurrent Massive Hemorrhagic Ascites and Diagnosed by Core Needle Biopsy: A Case Report. Medicine, 98, e15477. [Google Scholar] [CrossRef] 
[21] Lian, M., Zhang, C., Zhang, D., et al. (2019) The Association of Five Preoperative Serum Tumor Markers and Pathological Features in Patients with Breast Cancer. Journal of Clinical Laboratory Analysis, 33, e22875. [Google Scholar] [CrossRef] [PubMed]
[22] Levin, G., Herzberg, S., Dior, U.P., et al. (2019) The Predictive Role of CA-125 in the Management of Tubo-Ovarian Abscess. A Retrospective Study. European Journal of Obstetrics & Gynecology and Reproductive Biology, 238, 20-24. [Google Scholar] [CrossRef] [PubMed]
[23] Liu, M., Zhou, S., Wang, J., et al. (2019) Identification of Genes Associated with Survival of Breast Cancer Patients. Breast Cancer, 26, 317-325. [Google Scholar] [CrossRef] [PubMed]
[24] Stewart, A.F., Wu, T., Goumas, D., et al. (1987) N-Terminal Amino Acid Sequence of Two Novel Tumor-Derived Adenylate Cyclase-Stimulating Proteins: Identification of Parathyroid Hormone-Like and Parathyroid Hormone-Unlike Domains. Biochemical and Biophysical Research Communications, 146, 672-678. [Google Scholar] [CrossRef] 
[25] Southby, J., Kissin, M.W., Danks, J.A., et al. (1990) Immunohistochemical Localization of Parathyroid Hormone-Related Protein in Human Breast Cancer. Cancer Research, 50, 7710-7716.
[26] Grill, V., Ho, P., Body, J.J., et al. (1991) Parathyroid Hormone-Related Protein: Elevated Levels in Both Humoral Hypercalcemia of Malignancy and Hypercalcemia Complicating Metastatic Breast Cancer. The Journal of Clinical Endocrinology & Metabolism, 73, 1309-1315. [Google Scholar] [CrossRef] [PubMed]
[27] Powell, G.J., Southby, J., Danks, J.A., et al. (1991) Localization of Parathyroid Hormone-Related Protein in Breast Cancer Metastases: Increased Incidence in Bone Compared with Other Sites. Cancer Research, 51, 3059-3061.
[28] Martin, T.J. and Johnson, R.W. (2021) Multiple Actions of Parathyroid Hormone-Related Protein in Breast Cancer Bone Metastasis. British Journal of Pharmacology, 178, 1923-1935. [Google Scholar] [CrossRef] [PubMed]
[29] Yerram, P., Moore, R., Wolf, S., et al. (2019) Incidence of Skeletal Related Events in Patients with Bone Metastasis Receiving Denosumab Every Four Weeks Compared to Intervals Greater than Every Four Weeks. Journal of Oncology Pharmacy Practice, 25, 529-534. [Google Scholar] [CrossRef] [PubMed]
[30] Matuoka, J.Y., Kahn, J.G. and Secoli, S.R. (2019) Denosumab versus Bisphosphonates for the Treatment of Bone Metastases from Solid Tumors: A Systematic Review. The European Journal of Health Economics, 20, 487-499. [Google Scholar] [CrossRef] [PubMed]
[31] Nguyen, M.N., Akte, R.S., Akhter, H., et al. (2023) TOR1B: A Predictor of Bone Metastasis in Breast Cancer Patients. Scientific Reports, 13, Article No. 1495. [Google Scholar] [CrossRef] [PubMed]
[32] Haider, M.T., Ridlmaier, N., Smit, D.J., et al. (2021) Interleukins as Mediators of the Tumor Cell-Bone Cell Crosstalk during the Initiation of Breast Cancer Bone Metastasis. International Journal of Molecular Sciences, 22, Article 2898. [Google Scholar] [CrossRef] [PubMed]
[33] Avalos-Navarro, G., Muñoz-Valle, J.F., Daneri-Navarro, A., et al. (2019) Circulating Soluble Levels of MIF in Women with Breast Cancer in the Molecular Subtypes: Relationship with Th17 Cytokine Profile. Clinical and Experimental Medicine, 19, 385-391. [Google Scholar] [CrossRef] [PubMed]
[34] Chen, X. and Cubillos-Ruiz, J.R. (2021) Endoplasmic Reticulum Stress Signals in the Tumour and Its Microenvironment. Nature Reviews Cancer, 21, 71-88. [Google Scholar] [CrossRef] [PubMed]
[35] Wang, X., Yu, J., Wen, H., et al. (2023) Antioxidative Stress Protein SRXN1 Can Be Used as a Radiotherapy Prognostic Marker for Prostate Cancer. BMC Urology, 23, Article No. 148. [Google Scholar] [CrossRef] [PubMed]
[36] Puppo, M., Valluru, M.K. and Clézardin, P. (2021) MicroRNAs and Their Roles in Breast Cancer Bone Metastasis. Current Osteoporosis Reports, 19, 256-263. [Google Scholar] [CrossRef] [PubMed]
[37] Gomarasca, M., Maroni, P., Banfi, G., et al. (2020) MicroRNAs in the Antitumor Immune Response and in Bone Metastasis of Breast Cancer: From Biological Mechanisms to Therapeutics. International Journal of Molecular Sciences, 21, Article 2805. [Google Scholar] [CrossRef] [PubMed]
[38] Shin, E. and Koo, J.S. (2020) The Role of Adipokines and Bone Marrow Adipocytes in Breast Cancer Bone Metastasis. International Journal of Molecular Sciences, 21, Article 4967. [Google Scholar] [CrossRef] [PubMed]
[39] Khan, S., Shukla, S., Sinha, S., et al. (2013) Role of Adipokines and Cytokines in Obesity-Associated Breast Cancer: Therapeutic Targets. Cytokine & Growth Factor Reviews, 24, 503-513. [Google Scholar] [CrossRef] [PubMed]
[40] Soni, S., Torvund, M. and Mandal, C.C. (2021) Molecular Insights into the Interplay between Adiposity, Breast Cancer and Bone Metastasis. Clinical & Experimental Metastasis, 38, 119-138. [Google Scholar] [CrossRef] [PubMed]

为你推荐